NasdaqGS - Delayed Quote USD
Arcellx, Inc. (ACLX)
65.48
+0.34
+(0.52%)
At close: 4:00:01 PM EDT
65.48
0.00
(0.00%)
After hours: 4:20:00 PM EDT
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
711,327
825,132
313,817
128,782
Total Liabilities Net Minority Interest
256,535
339,752
108,863
250,297
Total Equity Gross Minority Interest
454,792
485,380
204,954
-121,515
Total Capitalization
454,792
485,380
204,954
-121,515
Common Stock Equity
454,792
485,380
204,954
-121,515
Capital Lease Obligations
54,080
97,625
88,131
0
Net Tangible Assets
454,792
485,380
204,954
-121,515
Working Capital
473,905
598,125
210,170
97,964
Invested Capital
454,792
485,380
204,954
-121,515
Tangible Book Value
454,792
485,380
204,954
-121,515
Total Debt
54,080
97,625
88,131
0
Share Issued
54,293.60
52,280.08
44,105.98
33,543.53
Ordinary Shares Number
54,293.60
52,280.08
44,105.98
33,543.53
12/31/2021 - 2/4/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NUVL Nuvalent, Inc.
76.82
-1.74%
APGE Apogee Therapeutics, Inc.
36.50
-1.56%
LEGN Legend Biotech Corporation
30.36
+6.79%
SRRK Scholar Rock Holding Corporation
30.82
-0.39%
INSM Insmed Incorporated
73.69
+0.83%
AKRO Akero Therapeutics, Inc.
52.99
+2.67%
MRUS Merus N.V.
57.58
-7.75%
CRNX Crinetics Pharmaceuticals, Inc.
32.13
+0.09%
PTGX Protagonist Therapeutics, Inc.
51.53
+0.92%
BLTE Belite Bio, Inc
65.28
+0.71%